Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23003,97,1.06 [0.88-1.27],0.5424810005633032
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23634,180,0.96 [0.84-1.10],0.5489771296837611
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23407,1152,1.01 [0.96-1.07],0.6055410445170313
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,23661,414,0.99 [0.90-1.08],0.8090996866726275
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22927,3033,1.02 [0.98-1.05],0.2943500001663415
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23129,2458,1.00 [0.96-1.04],0.9329046382675076
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23416,1165,1.02 [0.97-1.08],0.3781808204579966
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23564,81,0.93 [0.76-1.14],0.4890334131654582
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22093,696,0.99 [0.92-1.06],0.6841226273065142
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21340,796,1.00 [0.93-1.06],0.8877606050266924
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21385,219,0.99 [0.88-1.12],0.9162628133341214
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16579,1417,1.00 [0.95-1.05],0.997789462236386
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21191,315,1.00 [0.90-1.11],0.9688983137922786
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23604,1353,1.01 [0.96-1.06],0.6488507955533627
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Mycoses,23714,467,1.00 [0.92-1.08],0.9419936555533786
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23071,816,0.99 [0.93-1.05],0.6735365433187461
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23669,763,1.00 [0.93-1.06],0.908041560706972
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22431,180,0.96 [0.84-1.10],0.5597458047689987
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23772,37,1.00 [0.74-1.35],0.9921756119192848
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23581,675,0.99 [0.92-1.06],0.7253352154897685
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23558,75,1.01 [0.82-1.25],0.902506144323499
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23687,166,1.13 [0.98-1.30],0.0900855657470319
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23673,152,1.13 [0.97-1.30],0.1086757699458296
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22547,292,1.08 [0.97-1.20],0.1670784954254796
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22479,224,1.02 [0.90-1.15],0.8075925558246413
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22350,99,1.12 [0.94-1.35],0.2119924707892522
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23749,34,0.99 [0.73-1.34],0.9230069917376826
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23705,139,0.95 [0.82-1.11],0.5414264908709238
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Viral warts,23607,41,1.05 [0.80-1.40],0.7105258608750269
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23636,70,0.89 [0.71-1.10],0.2809904364275191
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm,23536,202,1.12 [0.99-1.28],0.068445770441944
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23683,58,1.10 [0.87-1.39],0.4466600461365941
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23676,57,1.28 [1.01-1.62],0.0403929035567997
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23518,1046,0.99 [0.93-1.04],0.664621472477197
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm of meninges,23747,73,1.03 [0.83-1.27],0.8085213179830554
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23715,59,1.08 [0.85-1.36],0.5385532857524156
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23741,117,1.07 [0.91-1.26],0.4247475410690781
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm of ovary,23704,147,1.07 [0.92-1.24],0.3978414961589576
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23752,236,0.95 [0.85-1.07],0.4204825610859901
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Caecum,23758,216,0.95 [0.84-1.07],0.4067043127551761
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23690,56,0.95 [0.74-1.21],0.6528966789766808
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,23756,133,0.81 [0.69-0.95],0.0093376412781342
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Rectum,23718,244,1.00 [0.89-1.12],0.9750828174551174
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23677,440,0.97 [0.89-1.06],0.5631700963732429
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23757,249,0.92 [0.82-1.03],0.1411918808454328
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Carcinoma in situ of breast,19223,122,0.83 [0.71-0.98],0.0301116094570559
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19295,142,0.94 [0.81-1.10],0.4358679826494076
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19289,30,0.87 [0.62-1.22],0.413640211265475
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19316,57,0.92 [0.72-1.18],0.5142582499731482
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23709,126,0.94 [0.80-1.10],0.4469036659556015
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Haemangioma, any site",23710,124,0.93 [0.79-1.10],0.3910795599017315
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Leiomyoma of uterus,22914,498,1.00 [0.92-1.08],0.9239985069360672
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Lung cancer and mesothelioma,17050,280,0.88 [0.79-0.98],0.0224360054788818
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Lymphoid leukaemia,19293,34,0.96 [0.70-1.31],0.7881352676650892
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19415,156,1.07 [0.93-1.24],0.3372857619586735
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19353,94,0.90 [0.74-1.08],0.2653000592350292
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19422,163,0.95 [0.82-1.09],0.4534494406158988
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19320,61,1.12 [0.89-1.42],0.3269638719030996
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19321,62,1.03 [0.81-1.29],0.8284118472964801
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19306,47,0.89 [0.68-1.17],0.4148225812573312
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19389,130,1.02 [0.87-1.20],0.789870016922667
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19351,92,1.08 [0.89-1.31],0.4210470519292378
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19329,70,0.99 [0.79-1.23],0.9132233596306212
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19295,36,0.97 [0.72-1.32],0.8680237439496113
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19329,70,0.86 [0.69-1.07],0.1787305325069372
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Melanocytic naevi,23539,203,1.16 [1.02-1.31],0.0211435015225606
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Melanocytic naevi of trunk,23733,68,1.16 [0.94-1.44],0.1749144067934381
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Melanoma in situ,19287,76,1.14 [0.93-1.40],0.2171956907952804
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19330,71,0.97 [0.78-1.21],0.7914917554437548
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19390,131,1.00 [0.85-1.17],0.97993197764728
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19465,206,0.78 [0.69-0.89],0.0001636113955799
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19340,81,1.10 [0.90-1.34],0.3736299925078525
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Other benign neoplasms of skin,23575,154,1.09 [0.94-1.26],0.2427270293728431
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",20055,796,1.00 [0.94-1.07],0.8998405183309305
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",20091,832,1.01 [0.94-1.07],0.843487560691995
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23488,340,0.95 [0.86-1.05],0.3481309976986358
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22042,85,0.97 [0.79-1.18],0.737808961003773
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23220,72,1.14 [0.92-1.41],0.2172054329834052
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22892,2572,1.03 [1.00-1.07],0.0635524527742373
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22366,27,1.04 [0.73-1.48],0.8164760849707857
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23422,46,1.35 [1.04-1.76],0.0267228238534508
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23264,1307,1.02 [0.97-1.07],0.4590221673376816
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23264,1307,1.02 [0.97-1.07],0.4590221673376816
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22025,68,0.96 [0.77-1.19],0.6939642216792878
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23412,1073,1.10 [1.04-1.17],0.0004965614564953
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23478,102,0.96 [0.80-1.15],0.6711139246522604
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23195,47,0.82 [0.63-1.07],0.1439723583827803
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23202,54,0.98 [0.77-1.26],0.8914319379967719
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23585,209,1.01 [0.89-1.15],0.846149667123149
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23680,53,1.19 [0.93-1.52],0.159181728601114
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23553,177,0.88 [0.77-1.01],0.0719600659132116
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22454,115,1.13 [0.96-1.34],0.1479260432019535
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,19173,209,0.98 [0.87-1.12],0.7996861198495031
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22530,61,0.83 [0.65-1.06],0.1386485149768311
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22526,57,1.11 [0.87-1.41],0.4204941183395614
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,19008,44,1.07 [0.81-1.41],0.6355702922290585
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21788,54,1.07 [0.84-1.36],0.5991362529397672
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21523,205,0.94 [0.83-1.07],0.3437852398495268
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23394,420,0.92 [0.84-1.00],0.0599864066264219
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23234,260,0.91 [0.81-1.02],0.0990529373448129
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23032,58,1.02 [0.81-1.30],0.8512622001721109
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23436,1702,1.01 [0.97-1.06],0.5425234835385808
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21068,1664,1.02 [0.97-1.06],0.4396106418070657
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",19007,43,1.02 [0.77-1.34],0.8996241851605297
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",21139,102,1.06 [0.88-1.26],0.5451588335664637
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,19210,246,1.05 [0.94-1.18],0.3667886421378464
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,19004,40,1.22 [0.92-1.62],0.1679384720111263
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21665,2701,1.04 [1.00-1.08],0.0284320219016167
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,19147,183,0.91 [0.80-1.04],0.174396990074839
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19435,471,1.00 [0.92-1.08],0.936123025091928
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23687,309,1.05 [0.95-1.17],0.312162292560923
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23523,145,1.08 [0.93-1.25],0.3420940884257279
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,19052,88,0.95 [0.78-1.15],0.577890875098074
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",19014,50,1.02 [0.79-1.32],0.8608608733288697
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23017,1980,1.03 [0.98-1.07],0.2282496737509769
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,19141,177,0.92 [0.80-1.06],0.2327113270563851
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,19135,171,1.12 [0.97-1.28],0.1237652199978499
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19422,458,1.00 [0.92-1.09],0.9480898009654166
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,19034,70,0.93 [0.75-1.16],0.5331495040849361
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23517,139,1.05 [0.90-1.22],0.5523440363452341
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19498,534,0.94 [0.87-1.01],0.1039044382952078
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19442,478,0.95 [0.87-1.03],0.232961981389387
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21380,62,1.11 [0.88-1.40],0.3630002777923362
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23007,4043,1.02 [0.99-1.05],0.1497335725887376
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,21100,63,0.93 [0.75-1.17],0.5541732892947907
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,21114,77,1.01 [0.82-1.24],0.91031763372818
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23606,1764,0.99 [0.95-1.03],0.5979445040364225
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23610,1763,0.99 [0.95-1.03],0.5992626298413427
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,21110,73,0.98 [0.79-1.21],0.8645157211519768
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23411,1369,1.04 [0.99-1.09],0.1177871326850228
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20260,1296,0.98 [0.93-1.03],0.4344827208033892
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23762,156,1.03 [0.89-1.19],0.7285087247791071
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,23016,42,1.04 [0.79-1.38],0.7643572632768683
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22161,119,0.97 [0.82-1.15],0.7455499700353605
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22211,169,1.11 [0.97-1.28],0.1414638360906033
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",19180,216,1.06 [0.93-1.20],0.3711806298206412
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22189,122,1.03 [0.87-1.21],0.7408067716008659
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1483,38,0.85 [0.63-1.17],0.3229831299041954
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1574,146,1.08 [0.93-1.26],0.3289504648774606
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22092,25,1.21 [0.84-1.74],0.2989172546137363
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1468,24,1.05 [0.72-1.54],0.7826673301859554
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23365,1298,1.02 [0.97-1.08],0.3773729517833906
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23264,290,0.92 [0.82-1.02],0.1110212760420695
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21736,418,0.99 [0.91-1.08],0.8029227056407919
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19579,615,0.98 [0.91-1.06],0.6532341172505087
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23685,206,0.86 [0.76-0.98],0.0221388350656348
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22878,42,0.83 [0.63-1.11],0.210115596665649
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Angina pectoris,22446,751,1.06 [1.00-1.14],0.062925772882447
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22914,78,0.81 [0.66-1.00],0.0510393229899233
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22866,30,1.09 [0.78-1.52],0.6172232181081043
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22975,139,0.95 [0.81-1.11],0.5214900857529423
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15441,1264,0.99 [0.94-1.05],0.8237936899980605
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,AV-block,20838,214,1.06 [0.94-1.20],0.3489156842965637
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23730,268,0.91 [0.81-1.02],0.0946723713729764
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,14284,107,1.04 [0.87-1.23],0.6964564580585688
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,20742,118,0.90 [0.76-1.06],0.2150895322009568
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",20695,71,1.16 [0.94-1.44],0.1616188678704464
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23768,27,0.85 [0.59-1.20],0.3502623838702769
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Conduction disorders,21257,633,1.04 [0.97-1.12],0.2955984371291775
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22980,1296,1.04 [0.99-1.09],0.1197957854769411
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21399,6314,1.01 [0.99-1.04],0.2313028094681431
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22480,218,0.91 [0.80-1.02],0.1158877260814955
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Endocarditis,20671,47,1.03 [0.79-1.34],0.8420997932236636
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23684,724,1.03 [0.96-1.10],0.4500061351585667
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Hypertension,21942,5309,1.01 [0.99-1.04],0.2679768233487471
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21951,5318,1.01 [0.99-1.04],0.2693091261839658
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23668,34,0.75 [0.54-1.02],0.0706028892667849
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16783,150,1.00 [0.86-1.16],0.9578791026403616
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16700,67,1.05 [0.84-1.32],0.6530952439322534
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Hypotension,23656,928,0.95 [0.90-1.01],0.0998320322899671
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23116,84,0.97 [0.80-1.18],0.7790294074665394
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23159,1464,1.05 [1.00-1.10],0.0315224159628189
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23501,397,0.98 [0.90-1.08],0.7168953103456834
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,20891,267,0.99 [0.89-1.11],0.9177956787827636
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23583,521,1.06 [0.98-1.14],0.1791132995419865
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22114,419,1.08 [0.99-1.18],0.0777060905166344
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23747,77,1.34 [1.09-1.64],0.0054654383351387
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23764,206,1.05 [0.93-1.19],0.4430730611648308
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,22294,32,0.75 [0.54-1.04],0.0829888707924717
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other aneurysm,22886,50,0.88 [0.68-1.14],0.3217625002561489
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,20942,318,1.03 [0.93-1.14],0.5945164696992333
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22897,61,1.14 [0.90-1.44],0.2659551572555179
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23008,172,0.94 [0.82-1.08],0.3759199309171196
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,20771,147,0.96 [0.83-1.12],0.6367294345441795
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,22335,73,0.99 [0.80-1.22],0.8972053057605851
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22303,41,0.99 [0.75-1.32],0.9583673706170748
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22689,30,0.79 [0.57-1.11],0.1733346232671643
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22396,134,0.98 [0.83-1.15],0.7841369593461907
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21303,679,1.00 [0.94-1.08],0.9359005299333936
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22764,36,0.82 [0.61-1.11],0.2069980798085804
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23283,447,0.93 [0.85-1.01],0.0778935386931754
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23263,284,0.95 [0.85-1.06],0.3409909655016583
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23124,465,0.95 [0.88-1.04],0.2726444946018737
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14428,251,1.04 [0.93-1.17],0.4791394989219119
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23071,246,0.89 [0.79-1.00],0.0503061657957111
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22544,282,0.94 [0.85-1.05],0.3078382255350923
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23365,386,1.02 [0.93-1.12],0.628071105237682
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23699,502,0.96 [0.89-1.04],0.3386418077494404
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,20809,185,1.08 [0.95-1.24],0.2465917247775193
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23256,277,0.95 [0.85-1.06],0.3825813888017083
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22793,134,0.87 [0.74-1.02],0.0827402204004384
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23492,460,0.98 [0.90-1.06],0.5906191381625925
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23468,500,0.97 [0.90-1.06],0.5346967011758008
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23085,62,1.01 [0.81-1.27],0.9163967211762474
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22872,36,0.97 [0.72-1.32],0.8689776658662173
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23286,182,1.07 [0.94-1.23],0.308513011264801
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23234,172,1.03 [0.90-1.19],0.6311353818337313
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Varicose veins,22642,380,1.03 [0.94-1.13],0.5370437857943938
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22846,84,0.82 [0.67-1.00],0.0478678724615341
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23587,606,0.99 [0.92-1.06],0.7149340159424764
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23734,198,0.97 [0.85-1.10],0.6478406868769456
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21111,1598,1.04 [0.99-1.08],0.1351933780937367
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Any mental disorder,23248,3735,1.02 [0.99-1.05],0.3150847637572943
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23709,235,0.94 [0.84-1.06],0.3270587643584864
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21231,1718,1.02 [0.98-1.07],0.3439896485074087
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19590,77,0.92 [0.75-1.13],0.4441763339871636
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Smoking dependency,23420,1037,1.02 [0.97-1.08],0.441460162549627
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20717,1204,1.01 [0.96-1.06],0.7683781523755177
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Vascular dementia,23349,90,0.91 [0.75-1.10],0.3167717845741423
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Alzheimer disease,23770,322,0.91 [0.83-1.01],0.0833795183740365
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",16263,51,0.97 [0.75-1.25],0.8113482734505985
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Bell's palsy,21911,70,0.90 [0.72-1.12],0.3347729106005577
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22392,551,1.04 [0.96-1.13],0.2965319465476458
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Cerebral cysts,23419,186,1.03 [0.91-1.18],0.6117580981617129
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23705,235,0.86 [0.76-0.97],0.0139606283167345
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23346,37,0.95 [0.70-1.28],0.7249443412103236
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23760,44,1.13 [0.86-1.48],0.3739649753860136
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23275,42,0.97 [0.74-1.29],0.8519909277595893
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Epilepsy,22516,246,0.94 [0.84-1.06],0.3213524694551577
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23410,1140,1.02 [0.96-1.07],0.5608856050172228
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23728,308,0.99 [0.89-1.10],0.8573284306108049
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23234,2507,0.94 [0.90-0.97],0.000337380759607
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,23454,41,1.13 [0.86-1.50],0.3817275276905644
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Hemiplegia,23657,187,0.87 [0.76-1.00],0.0452856821999091
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Hydrocephalus,23288,55,1.07 [0.84-1.36],0.5900102219352981
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23754,65,1.06 [0.85-1.32],0.6198078669619622
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21954,113,0.93 [0.79-1.11],0.4178785511104481
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21896,55,1.19 [0.93-1.52],0.1567485430402438
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Memory loss,23240,93,1.01 [0.84-1.22],0.9358808115028582
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Migraine,22708,438,1.03 [0.94-1.12],0.5145062765387296
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23672,397,1.03 [0.94-1.12],0.5583528734184218
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Motor neuron disease,16350,113,1.04 [0.88-1.23],0.6654079641216251
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23572,126,1.00 [0.85-1.17],0.9550530591450442
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23047,1206,1.02 [0.97-1.08],0.3775162236711489
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Neurological diseases,22369,3210,0.99 [0.96-1.03],0.7340577265917603
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23436,127,0.92 [0.79-1.09],0.3445472027165788
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22208,367,1.04 [0.94-1.14],0.4679130863714749
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23717,196,1.01 [0.89-1.15],0.8576278308843579
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19219,578,0.94 [0.87-1.01],0.1118402909023769
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23291,58,0.96 [0.76-1.21],0.7192236853115705
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23344,111,0.84 [0.71-1.00],0.0509895076636871
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23564,144,0.99 [0.85-1.15],0.8835504460751021
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21919,78,0.92 [0.75-1.13],0.4378044202539184
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other headache syndromes,22336,66,1.07 [0.86-1.33],0.5609279831691383
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other neurological diseases,23668,435,1.03 [0.94-1.12],0.5470225224486449
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other sleep disorders,22612,342,1.01 [0.92-1.12],0.832772575637458
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Parkinson's disease,23748,144,0.99 [0.85-1.15],0.897602106179721
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23306,73,1.10 [0.89-1.35],0.3862662280349809
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,23769,78,0.99 [0.81-1.22],0.918865933147406
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Sleep apnoea,23619,276,0.99 [0.89-1.11],0.9091301063253072
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23555,34,1.08 [0.79-1.48],0.6210027628374264
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23760,138,0.96 [0.82-1.12],0.6025354556523845
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21902,61,1.06 [0.84-1.34],0.6039604384970226
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23770,325,0.92 [0.83-1.01],0.0923865323397131
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23309,87,0.91 [0.75-1.11],0.3421382153975238
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23255,93,0.95 [0.79-1.15],0.5948197338864742
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23370,424,0.96 [0.88-1.05],0.3479570825774912
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23643,138,1.08 [0.92-1.26],0.3545113885206359
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22805,51,1.11 [0.86-1.43],0.4092074638816578
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22802,48,1.25 [0.97-1.62],0.0827215825695803
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23663,57,1.13 [0.89-1.43],0.3257158865634786
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23520,147,0.88 [0.76-1.03],0.1099630652168331
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1475,30,1.13 [0.80-1.58],0.4925876206552654
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1761,56,0.93 [0.72-1.20],0.5724021445183484
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23244,82,0.94 [0.77-1.15],0.5507972302875279
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23619,910,1.05 [0.99-1.11],0.1354618943730575
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23402,648,0.99 [0.93-1.07],0.8849489854696134
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23014,260,0.99 [0.88-1.10],0.795281067933344
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23693,747,0.99 [0.93-1.06],0.8214934407174269
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23758,61,0.97 [0.77-1.23],0.8212148268542436
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23625,679,0.99 [0.92-1.06],0.6914119583488552
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23732,359,0.97 [0.88-1.06],0.4908388977561471
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23685,184,0.92 [0.80-1.05],0.1913808804083825
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22792,38,1.06 [0.79-1.43],0.6926442376544506
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22796,42,1.23 [0.93-1.63],0.1529282592611809
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22815,61,1.05 [0.83-1.32],0.689299408116191
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23691,619,0.99 [0.92-1.07],0.8413448230065607
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23221,149,0.93 [0.80-1.07],0.3074126343260757
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23003,57,0.98 [0.77-1.25],0.8742930598705875
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23463,90,1.06 [0.88-1.28],0.5387113379281948
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23651,278,0.93 [0.84-1.04],0.2197381188256465
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23126,180,1.00 [0.87-1.14],0.9998746588097118
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23620,119,0.94 [0.80-1.11],0.4625474246621818
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23475,403,0.98 [0.90-1.08],0.6998039356397432
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23300,138,0.95 [0.82-1.11],0.5558177476489373
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22204,2210,1.02 [0.98-1.06],0.2391128813160724
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23618,245,0.93 [0.83-1.05],0.2462267398766975
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23748,144,1.05 [0.91-1.22],0.4983748984785707
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23086,332,1.03 [0.93-1.14],0.5909435804744807
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23431,58,1.02 [0.80-1.30],0.8599992856825839
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23746,49,1.06 [0.82-1.37],0.6612941432176945
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22837,83,0.94 [0.77-1.15],0.5504619096459985
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22881,127,0.90 [0.77-1.06],0.2227264450091476
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22802,93,1.08 [0.89-1.30],0.42608077751334
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23003,57,1.10 [0.87-1.39],0.4452098953415961
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22765,56,0.89 [0.70-1.14],0.3595072656879106
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23176,104,1.02 [0.86-1.22],0.8082359221342348
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23230,158,0.92 [0.80-1.07],0.290630882390037
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22865,111,1.12 [0.94-1.33],0.1985615161066689
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22791,82,1.25 [1.03-1.52],0.0246395934635032
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22767,58,1.13 [0.89-1.43],0.3162826519680763
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21817,1823,0.97 [0.93-1.01],0.1998374809107811
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22829,75,1.07 [0.87-1.32],0.5177394491360898
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23541,379,0.96 [0.88-1.05],0.4039031324456874
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23202,40,0.88 [0.66-1.17],0.3779051570008102
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23310,148,1.13 [0.97-1.31],0.1178682808759686
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23546,101,0.93 [0.77-1.11],0.4138124912279055
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23731,94,0.94 [0.78-1.13],0.5087508913365317
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23666,124,0.97 [0.82-1.14],0.6808482394663
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23509,64,0.96 [0.77-1.21],0.757942464920812
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23511,66,1.04 [0.83-1.30],0.7157568655524977
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23677,702,1.01 [0.94-1.08],0.8147791267752288
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23456,481,1.03 [0.95-1.12],0.4961592258408999
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23078,103,0.95 [0.80-1.14],0.6018235245399199
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23048,73,1.19 [0.97-1.47],0.0983614400961481
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,23530,74,0.83 [0.67-1.03],0.0842769881676283
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23664,208,0.89 [0.79-1.01],0.0768972456135647
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23512,56,0.91 [0.71-1.15],0.4178162476713369
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,All influenza,22287,113,0.92 [0.78-1.10],0.3553199985957485
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22286,112,0.93 [0.78-1.10],0.3799287326232728
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),16887,117,1.07 [0.90-1.26],0.436839161447442
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,23648,251,1.16 [1.03-1.29],0.0118880578406748
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18433,1822,1.03 [0.99-1.07],0.203739895596252
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18568,1798,1.03 [0.98-1.07],0.2085009690342749
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23408,113,1.05 [0.89-1.24],0.5775394197549553
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22234,60,1.11 [0.88-1.40],0.3690146272101858
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Bronchiectasis,20525,345,1.09 [0.99-1.20],0.0766081932991568
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20241,61,1.08 [0.85-1.36],0.5265630715406033
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22772,2592,1.02 [0.99-1.06],0.2498096044171755
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22661,59,0.86 [0.68-1.09],0.2067881511449072
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22727,125,1.05 [0.90-1.24],0.5385763738955934
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23620,897,1.01 [0.95-1.07],0.79167428255307
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22666,64,1.04 [0.83-1.30],0.7370444623383778
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21950,4473,1.03 [1.00-1.06],0.0266662962230221
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22893,291,1.05 [0.95-1.17],0.3485566855143769
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Early onset COPD,23001,278,1.02 [0.92-1.14],0.6698339432655385
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Emphysema,20410,230,1.06 [0.94-1.20],0.308639518005961
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22309,202,0.91 [0.80-1.04],0.1662301684607526
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23596,1422,0.98 [0.94-1.03],0.4565343434817832
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22344,237,0.94 [0.83-1.06],0.2901434016611489
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Later onset COPD,22967,619,1.00 [0.93-1.08],0.9456848375008908
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23763,190,0.92 [0.81-1.05],0.2278675243323509
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Nasal polyp,22662,60,1.02 [0.81-1.29],0.8639662585476275
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23572,803,1.00 [0.94-1.07],0.9742518499433486
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,23604,1519,0.99 [0.95-1.04],0.7999090206326099
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23286,684,1.10 [1.03-1.18],0.0055046815149118
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other pleural conditions,22120,35,0.77 [0.57-1.05],0.0960650955013658
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23695,299,0.92 [0.83-1.02],0.1153703935140361
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23690,1031,1.03 [0.97-1.09],0.3530125719600265
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pleural effusion,22808,723,0.97 [0.91-1.04],0.3870593033972388
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pleural plaque,22128,43,1.02 [0.77-1.35],0.8955967095513655
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23386,1212,0.98 [0.93-1.03],0.4498965268644125
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23737,164,0.92 [0.80-1.06],0.2385604549657656
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pneumothorax,22174,89,0.96 [0.79-1.16],0.6405012700870658
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pollen allergy,23746,211,1.14 [1.01-1.29],0.0406255100932467
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,23450,54,0.81 [0.63-1.04],0.0973010371619792
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,16812,42,1.26 [0.94-1.70],0.1289555680671018
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23553,784,0.99 [0.93-1.06],0.8288663971133085
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22853,251,1.16 [1.03-1.30],0.0107670737314178
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Viral pneumonia,22356,182,1.00 [0.87-1.14],0.99157497757174
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23416,144,0.98 [0.84-1.14],0.7824002746285701
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11433,89,1.02 [0.84-1.24],0.8380577289406883
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16982,35,1.01 [0.74-1.37],0.972220076890888
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Acute appendicitis,23600,120,0.83 [0.70-0.98],0.0293087922493388
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Acute gastritis,17834,71,1.02 [0.83-1.27],0.8334679635566864
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,21789,144,1.06 [0.91-1.23],0.4359758016678416
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Acute peritonitis,23267,75,1.10 [0.89-1.36],0.3727947362619936
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23019,31,0.87 [0.62-1.21],0.3938212014079038
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,18063,300,1.11 [1.00-1.23],0.0597305426349712
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21715,70,1.22 [0.98-1.52],0.0719701067534203
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23399,70,1.22 [0.98-1.51],0.0728807168551876
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Cholecystitis,21797,152,0.98 [0.84-1.14],0.780520341400881
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Cholelithiasis,22684,1039,1.00 [0.94-1.05],0.9110049290694516
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Chronic gastritis,18057,294,1.14 [1.02-1.26],0.0178309800675121
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21681,36,0.84 [0.62-1.14],0.2665383294679572
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23698,64,0.81 [0.64-1.02],0.0762652083494265
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Coeliac disease,22443,123,1.02 [0.87-1.20],0.8053673806657755
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Collagenous colitis,22123,90,0.89 [0.74-1.08],0.2476214164446687
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23649,141,1.00 [0.86-1.17],0.9682177569307844
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Constipation,23476,1475,1.00 [0.95-1.05],0.9735550211130228
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Crohn disease,22108,75,0.94 [0.76-1.15],0.5383737852035635
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23453,53,0.92 [0.71-1.18],0.5018377006979782
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22110,77,0.95 [0.77-1.17],0.6238629861163054
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Dental caries,23049,203,0.99 [0.87-1.12],0.8638294504601989
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22348,2119,1.03 [0.99-1.07],0.1952463538265657
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of appendix,23639,159,0.94 [0.81-1.08],0.3919766500667244
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of liver,23683,695,1.01 [0.94-1.08],0.8793877120011493
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21771,4008,0.99 [0.97-1.02],0.6863805514015476
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23364,518,1.01 [0.94-1.10],0.7122951728453497
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23660,468,1.03 [0.95-1.12],0.506931435435604
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22952,106,0.96 [0.80-1.14],0.6178136769058746
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22817,57,0.96 [0.76-1.22],0.7435652319913039
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23520,1200,0.98 [0.93-1.03],0.4967619491584714
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of tongue,22822,93,1.00 [0.83-1.21],0.9879609154235302
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23034,1389,1.01 [0.96-1.06],0.7724820904828121
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19726,2779,1.00 [0.97-1.04],0.950350834681634
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,17880,117,1.05 [0.89-1.24],0.5742163423388906
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23721,97,1.00 [0.83-1.21],0.9761291208556492
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23686,55,1.28 [1.01-1.62],0.0429936063193533
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23070,82,0.88 [0.72-1.08],0.233740203608487
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,17050,103,1.07 [0.90-1.28],0.4437825706974007
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,18346,583,1.04 [0.96-1.12],0.3202675885701457
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastric ulcer,18068,305,0.98 [0.88-1.09],0.7173464983722706
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20184,2421,1.00 [0.96-1.03],0.8493619471024791
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18183,420,0.99 [0.91-1.09],0.8801442331017543
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18590,7292,1.00 [0.98-1.02],0.9908314718381762
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,GI-bleeding,23282,962,0.97 [0.92-1.03],0.3651918080027123
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22908,62,0.95 [0.76-1.20],0.6814700527562538
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17790,1089,1.06 [1.00-1.11],0.0531160477064197
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23020,32,0.72 [0.52-0.99],0.0454250226873982
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Hernia,22731,2502,1.01 [0.98-1.05],0.5368695290471563
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Impacted teeth,23694,50,1.35 [1.05-1.72],0.0187506890592183
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Impaction of intestines,17008,61,1.06 [0.84-1.34],0.6092739245754022
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Inguinal hernia,20375,146,0.86 [0.74-1.01],0.0594791040883604
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,17031,84,0.82 [0.68-1.00],0.055855711149623
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22468,148,1.04 [0.90-1.20],0.6277718175016949
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17646,699,1.03 [0.96-1.10],0.3683930623519522
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23760,300,1.13 [1.01-1.25],0.0276913816065335
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22740,707,1.06 [0.99-1.13],0.1217355064740598
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22981,948,1.04 [0.98-1.11],0.1512201067796561
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17895,132,1.10 [0.94-1.29],0.2371920113750351
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Oesophagitis,18265,502,1.03 [0.95-1.12],0.490262769760349
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23729,139,1.03 [0.89-1.20],0.6824981744890163
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20283,54,1.06 [0.83-1.37],0.6267613436034185
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18033,1086,0.99 [0.94-1.05],0.7290470129037392
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21899,254,1.01 [0.90-1.13],0.8897936168868229
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21812,167,0.97 [0.84-1.12],0.6940891839480837
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,18317,1370,0.98 [0.94-1.03],0.5227590427306517
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,21887,4940,0.99 [0.97-1.02],0.4583141672095414
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22822,201,1.03 [0.90-1.17],0.6954989627583925
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of liver,23566,578,1.02 [0.95-1.10],0.570680680890103
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18277,514,1.01 [0.94-1.10],0.7476272869260605
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21783,138,0.92 [0.79-1.08],0.3044554264511414
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23602,410,1.02 [0.93-1.11],0.7320333536466906
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18693,930,0.99 [0.94-1.05],0.8063808257270293
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23298,978,0.97 [0.92-1.03],0.3718300050927424
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23002,156,0.99 [0.86-1.15],0.939549748058408
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18472,1525,1.00 [0.96-1.05],0.9034382889059128
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19596,1833,0.97 [0.93-1.01],0.1937346551752311
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23077,89,0.88 [0.73-1.07],0.2070885791259712
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22867,834,1.03 [0.97-1.10],0.3196753585927936
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17238,291,0.92 [0.83-1.02],0.1309793985792296
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23676,64,1.26 [1.01-1.57],0.0413723445806201
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17378,431,0.90 [0.83-0.99],0.0224558856672703
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22441,121,0.95 [0.80-1.11],0.5043380625196789
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23762,64,0.84 [0.67-1.05],0.1207222822104227
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22848,116,0.90 [0.76-1.07],0.2285739744076693
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Toxic colitis,22088,55,0.99 [0.78-1.27],0.9571426053129308
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17973,210,1.11 [0.98-1.26],0.1015016576605079
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,22182,149,1.11 [0.96-1.28],0.1701180396561925
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22159,126,1.14 [0.97-1.34],0.1013589313141424
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Umbilical hernia,20381,152,0.92 [0.79-1.07],0.2694744449656272
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,17115,168,0.92 [0.80-1.06],0.2690955947734065
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Ventral hernia,20449,220,0.97 [0.86-1.09],0.5947150320921811
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Volvulus,17020,73,0.91 [0.74-1.13],0.4073135707460605
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23694,216,1.14 [1.01-1.29],0.0375174494041055
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23493,76,0.80 [0.65-0.99],0.0366339755376839
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21990,195,1.05 [0.92-1.20],0.4446573863541744
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23295,547,0.96 [0.89-1.04],0.3264334034922811
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22878,130,1.03 [0.88-1.21],0.7285017937035161
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22076,281,0.93 [0.83-1.04],0.1791062295916257
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23496,238,1.05 [0.94-1.19],0.3721461385922285
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23671,413,0.98 [0.89-1.07],0.6093615406814652
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23302,44,0.91 [0.69-1.20],0.4924097084882161
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22381,2746,1.01 [0.97-1.04],0.7576736946787314
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23376,407,0.97 [0.89-1.06],0.5200474450754227
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23246,277,1.01 [0.91-1.12],0.8666402961514866
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23486,738,0.96 [0.90-1.03],0.2836111364579785
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23752,66,1.06 [0.85-1.32],0.6221039079726367
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21882,87,0.91 [0.75-1.11],0.3423882725924757
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23010,41,1.08 [0.81-1.43],0.6050372873284436
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23482,224,1.06 [0.94-1.20],0.3112186641109542
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22157,362,1.09 [0.99-1.20],0.0824962859881897
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21842,47,0.89 [0.68-1.15],0.366734540951094
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23681,70,0.83 [0.67-1.03],0.0970947711311506
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22881,133,1.06 [0.90-1.24],0.4824143907896494
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23564,147,0.73 [0.62-0.85],3.828195960321804e-05
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23300,42,0.88 [0.66-1.17],0.3693236442328106
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21851,56,1.02 [0.80-1.29],0.8833013745786245
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23186,1391,1.01 [0.96-1.06],0.6519314323542917
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22187,392,1.07 [0.98-1.17],0.1299893468629125
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21846,51,0.89 [0.69-1.15],0.3798043444323921
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23695,278,0.87 [0.78-0.97],0.0116271363049734
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23332,74,0.81 [0.65-1.00],0.049520936107954
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23632,215,0.82 [0.72-0.93],0.0015952416008355
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23722,244,1.14 [1.01-1.28],0.0283436816470145
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21936,141,1.13 [0.97-1.31],0.1191687455935591
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22022,227,1.11 [0.99-1.25],0.0790362523228839
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23710,232,1.12 [1.00-1.26],0.0563679471052594
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21972,177,1.05 [0.91-1.20],0.5204148721712497
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23739,128,0.91 [0.78-1.07],0.2731400121958303
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20276,115,1.11 [0.94-1.31],0.2309029097745512
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21595,5543,1.00 [0.97-1.02],0.7143042893184077
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20389,4337,1.01 [0.99-1.04],0.340802727622463
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20228,67,0.94 [0.76-1.17],0.5964627537854927
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20385,134,0.99 [0.85-1.16],0.9050034412703007
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20434,183,1.01 [0.88-1.15],0.9272357745240832
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23522,102,0.84 [0.70-1.00],0.0497177980522112
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20356,105,0.97 [0.81-1.15],0.7048411300523754
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17256,1204,1.00 [0.95-1.06],0.8712620611462055
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23628,200,1.02 [0.90-1.16],0.7614410887887456
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20757,506,1.02 [0.94-1.10],0.6541817408802831
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19969,7068,1.00 [0.98-1.02],0.7951043267859889
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21275,116,1.01 [0.85-1.19],0.944510073254354
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20282,121,1.09 [0.92-1.28],0.3164065543120024
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20763,602,1.04 [0.97-1.12],0.2817760911154943
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22872,2621,1.01 [0.97-1.04],0.7586165818150518
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20319,158,1.04 [0.90-1.20],0.6138674419724446
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20500,339,1.13 [1.03-1.25],0.0128526967373723
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20316,155,1.18 [1.02-1.36],0.0273836286834777
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22905,93,0.90 [0.75-1.09],0.299916474805713
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17682,1630,1.01 [0.97-1.06],0.66797279484368
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16232,180,1.06 [0.92-1.21],0.4050555642407776
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23758,177,1.04 [0.91-1.20],0.5471677729089173
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16144,92,1.05 [0.87-1.27],0.6143939182757674
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16558,506,0.92 [0.85-0.99],0.0357342015753693
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20453,292,0.96 [0.86-1.06],0.3997131819843689
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16600,548,0.99 [0.92-1.07],0.7922354428119938
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20309,58,1.15 [0.91-1.46],0.2469346706580409
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20872,621,1.06 [0.99-1.14],0.0959619773527046
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20542,291,1.03 [0.93-1.14],0.5974910653338923
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16560,508,0.99 [0.92-1.08],0.8524559272222336
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20236,75,1.21 [0.98-1.48],0.0716468592763264
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20219,58,0.99 [0.78-1.26],0.9587381130798612
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,21204,45,1.12 [0.85-1.47],0.416707632304981
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23357,2198,0.96 [0.93-1.00],0.0675837242393312
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22744,1585,0.96 [0.92-1.01],0.1187644118128769
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23594,521,1.05 [0.97-1.13],0.2497236552964038
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18709,2657,1.00 [0.97-1.04],0.8318104394098662
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16112,60,0.91 [0.72-1.15],0.4384949565114672
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20250,89,1.20 [0.99-1.44],0.0650871191434571
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16093,41,0.93 [0.70-1.23],0.598861139042716
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16233,181,1.00 [0.87-1.15],0.9957064315050574
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21419,260,0.92 [0.82-1.03],0.1544685344671417
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21656,497,0.93 [0.86-1.01],0.1017715357952645
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23746,96,1.04 [0.86-1.25],0.7070792287145138
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22022,1771,1.03 [0.98-1.07],0.2588902044833985
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20274,113,0.95 [0.81-1.13],0.58251462725178
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16258,206,0.89 [0.78-1.01],0.0746948621270055
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20956,705,1.01 [0.95-1.09],0.6787231297739617
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18271,2219,0.98 [0.94-1.02],0.2668249842185554
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22925,113,0.91 [0.77-1.08],0.2812575622566149
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23752,75,0.86 [0.70-1.07],0.171924348247545
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20227,66,1.03 [0.82-1.29],0.7894193561371515
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21441,1280,1.04 [0.99-1.10],0.1093850978748674
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20234,73,1.07 [0.86-1.32],0.5562428842974969
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17784,1732,1.03 [0.99-1.08],0.1254369517615426
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21286,127,0.97 [0.82-1.14],0.7025791058371701
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20210,49,0.95 [0.73-1.23],0.6913385750447624
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20424,173,0.93 [0.81-1.07],0.3105779778631787
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20659,498,0.99 [0.91-1.07],0.7175389086522759
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23264,452,1.08 [0.99-1.18],0.0711976996954274
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20811,560,1.04 [0.96-1.12],0.3336902267726134
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23606,503,1.06 [0.98-1.15],0.1711822467209144
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23745,56,1.15 [0.90-1.46],0.2623618775033742
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20357,196,0.98 [0.86-1.12],0.8084490727645948
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18212,791,1.02 [0.96-1.09],0.4697700104140107
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20737,576,1.02 [0.95-1.10],0.623674162582404
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20269,108,1.07 [0.90-1.27],0.4535211257215139
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16124,72,0.95 [0.77-1.18],0.6449038364414768
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18355,2303,1.03 [0.99-1.07],0.1851620188889282
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16780,728,1.03 [0.96-1.10],0.4196693642103491
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23068,256,1.11 [0.99-1.25],0.0677091637867886
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23720,70,0.96 [0.77-1.19],0.6882152201277512
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21783,48,1.22 [0.94-1.58],0.1399643047105682
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16128,76,0.84 [0.69-1.04],0.1131676270970658
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20348,97,1.08 [0.90-1.30],0.3891338590284076
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16576,524,1.06 [0.98-1.14],0.1757836317708362
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20443,282,0.92 [0.83-1.03],0.1479752754069154
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20500,249,1.06 [0.94-1.18],0.3602156734386815
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20490,239,1.01 [0.89-1.13],0.9234128004350792
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18331,77,1.14 [0.93-1.40],0.1991318144967486
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23751,62,1.06 [0.84-1.33],0.6265498672738279
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20714,553,1.00 [0.92-1.08],0.9550195053461654
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],22961,149,1.05 [0.91-1.22],0.5184052427282811
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22616,2455,1.03 [0.99-1.06],0.1568454231209847
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20299,138,0.85 [0.72-0.99],0.0331848278490573
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20731,480,1.02 [0.94-1.10],0.7044864835314198
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22236,226,0.93 [0.83-1.05],0.2582886575714915
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20467,216,1.00 [0.88-1.13],0.9487117065481468
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21760,1509,0.97 [0.93-1.02],0.2411751730816515
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21275,1024,0.97 [0.92-1.03],0.3332993880158624
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20215,54,1.07 [0.83-1.36],0.6069424569968547
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23025,213,0.95 [0.84-1.08],0.454143682210784
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20332,171,1.00 [0.87-1.15],0.9641031026960823
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20277,116,0.85 [0.71-1.00],0.0524608891751787
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16095,43,1.11 [0.85-1.47],0.4439167410569758
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22926,1036,0.99 [0.93-1.05],0.7052104090612155
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17773,87,1.06 [0.88-1.29],0.5443672931371095
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23166,98,0.92 [0.77-1.10],0.3748193559484547
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23632,198,1.08 [0.95-1.23],0.2163630801037714
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23455,21,0.69 [0.46-1.03],0.070579786111219
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23052,1162,1.00 [0.94-1.05],0.9011939229146136
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23624,56,0.80 [0.63-1.03],0.078766253424029
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23596,203,0.96 [0.84-1.09],0.4848401311015
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Cystitis,20991,218,0.90 [0.80-1.02],0.1062457303180284
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Dialysis,21935,45,1.20 [0.91-1.56],0.1916925621506467
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23352,284,0.98 [0.88-1.09],0.6893171537722946
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,17837,151,1.02 [0.88-1.18],0.8235046028089408
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18023,337,0.92 [0.84-1.02],0.1120119482149249
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18557,871,1.02 [0.96-1.09],0.4522377869226816
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18478,4305,1.00 [0.97-1.03],0.992111764003103
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23623,55,1.07 [0.84-1.37],0.5789789139172994
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,21774,181,0.94 [0.82-1.07],0.3456491945574019
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23293,347,0.98 [0.89-1.08],0.6647014530296917
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,23362,108,0.76 [0.64-0.90],0.0017955879463952
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17949,263,1.03 [0.92-1.15],0.6109035723845677
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20838,65,1.09 [0.87-1.36],0.4666905185416136
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19800,2114,0.99 [0.95-1.03],0.5301859098360338
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17804,118,1.03 [0.87-1.22],0.7253304261441451
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23761,57,1.09 [0.85-1.38],0.5020180333611295
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23761,70,0.88 [0.71-1.10],0.2697552832690669
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22697,1924,1.00 [0.96-1.04],0.8582062629078919
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21183,410,0.99 [0.91-1.08],0.8426633076899842
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23169,101,0.99 [0.83-1.19],0.9354462167366846
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23718,325,1.00 [0.90-1.10],0.9627462465323108
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23717,76,1.01 [0.82-1.24],0.9346723344284212
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22424,1651,1.01 [0.96-1.05],0.7629114781591644
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23126,180,1.04 [0.91-1.19],0.5820582913608701
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17818,132,1.14 [0.98-1.33],0.0970970113357685
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18020,334,1.01 [0.91-1.11],0.8509764119837984
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17789,103,1.07 [0.90-1.28],0.4616716303120753
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17868,182,1.07 [0.93-1.22],0.3453305710666212
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21818,225,0.97 [0.86-1.10],0.644447559338407
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23500,107,1.05 [0.88-1.25],0.6179282826331219
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17946,260,1.03 [0.92-1.15],0.6462060858401578
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17777,91,0.86 [0.71-1.04],0.1126281548235839
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18235,549,0.98 [0.91-1.06],0.5845836308013191
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17823,137,1.11 [0.95-1.30],0.1809417944632244
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18192,506,0.95 [0.88-1.03],0.2254471628088565
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23602,34,1.07 [0.78-1.46],0.6725453371747152
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23620,2027,1.00 [0.96-1.04],0.9068061440879336
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",21736,143,1.04 [0.89-1.21],0.6347558685277501
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21970,80,1.03 [0.84-1.27],0.758318313523617
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23466,32,0.89 [0.65-1.23],0.4731674254792429
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20900,127,1.02 [0.87-1.20],0.7991893822690268
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23662,228,1.05 [0.94-1.19],0.3811877378599568
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17805,119,1.07 [0.91-1.26],0.4365623169794729
